Albany International (AIN) Q1 2025 earnings summary

Executive summary

• Q1 2025 net revenues were $289 million, down 7.8% year-over-year, with both Machine Clothing (MC) and Albany Engineered Composites (AEC) segments experiencing lower sales; integration of Heimbach is progressing as planned.

• Net income attributable to the company was $17 million ($0.56 per share), down from $27 million ($0.87 per share) in Q1 2024; adjusted diluted EPS was $0.73, down from $0.90.

• Gross profit margin decreased to 33.4% from 34.7% year-over-year, mainly due to lower profitability in AEC's long-term contracts.

• Operating income fell to $28 million from $39 million, reflecting lower segment profits and higher restructuring charges.

• Free cash flow was negative $13 million, an improvement from negative $17 million in the prior year.

Financial highlights

• Consolidated net sales were $289 million, down 7.8% year-over-year from $313 million.

• Adjusted EBITDA was $56 million (19.3% margin), down from $65 million last year; adjusted diluted EPS was $0.73 versus $0.90.

• MC segment revenues decreased 5.7% to $174.7 million; AEC segment revenues declined 11.0% to $114.1 million year-over-year.

• MC gross margin remained stable at 45.7%; AEC gross margin dropped to 14.5% from 18.8% due to $7 million in negative contract profitability adjustments.

• SG&A expenses were $54 million, slightly down year-over-year; effective tax rate 26.6% versus 29.2%.

Outlook and guidance

• Full-year 2025 revenue guidance reaffirmed at $1.165–$1.265 billion; adjusted diluted EPS expected between $3.00 and $3.40.

• MC expects continued revenue declines in publication grades, offset by growth in packaging and tissue in Europe; backlog remains stable.

• AEC continues to ramp up production on commercial, defense, and space programs, but faces margin pressure from cost and estimate revisions on long-term contracts.

• 2025 expected to be another strong free cash flow year; management anticipates adequate liquidity and compliance with debt covenants.

• Capital expenditures projected at $85–$95 million; effective tax rate around 31%.